Goodwin Advises Teachers' Venture Growth on Alan's €480 Million Series G Financing

The Mechanics of a G-Round

By the time a company is writing Series G cheques, the cap table is crowded, the dilution math is ugly, and the next stop is either an IPO or a down-round reset. Alan was founded in 2016, so the path here is roughly a decade of raises before landing at €5.5B.

What the filings confirm:

• Round: €480M Series G
• Post-money valuation: €5.5B
• Lead: Prosus
• Participating investor: Teachers' Venture Growth (the late-stage platform of Ontario Teachers' Pension Plan, Canada's largest single-profession pension plan)
• Counsel to TVG: Goodwin Procter, Paris PE team — Benjamin Garçon leading, with Louis Taslé d'Héliand and Grégoire Mongis on corporate
• Closing: subject to regulatory approvals

What they don't disclose, and what actually matters at this stage: primary versus secondary split, option pool refresh, and whether existing holders got any liquidity. At a G-round, somebody usually cashes out. If the round is mostly primary, the €5.5B is a real cost basis to defend; if it's mostly secondary, it's a partial exit dressed as a financing.

The LP Read

Ontario Teachers' writing into a French health insurer at €5.5B is a positioning signal — not about Alan specifically, but about where the big Canadian pools are parking late-stage euros. When TVG moves at this size, the smaller funds tend to follow six to twelve months later, usually through co-invest.

Three things to track:

• Regulatory clock. Solvency II, ACPR oversight, capital buffers. "Digital-first" is a marketing line; the regulator doesn't grade your app design. The approval timeline is the real milestone here.
• Liquidity path. A €5.5B G-round in EU health insurance usually points toward a Paris or Amsterdam listing. Watch for prospectus leaks and banking-mandate chatter.
• Prosus's posture. Prosus has been a serial writer into European tech. When they lead at the G, they're usually anchoring an exit narrative, not just underwriting the next bridge. If Prosus is rotating out at IPO, TVG just became the bag-holder with regulatory upside.

What this actually means for LPs: this is late-stage venture, not growth equity. The bet is the exit, and the exit now runs through a regulator who has no reason to be friendly.A French health insurer just printed a €5.5 billion paper mark on its cap table. Alan closed a €480 million Series G led by Prosus, with Teachers' Venture Growth — the late-stage venture arm of Ontario Teachers' Pension Plan — riding along. Goodwin Procter's Paris desk advised TVG on the participation. Closing is gated by regulatory approvals, and in EU insurance that is not a rubber stamp.

The Mechanics of a G-Round

By the time a company is writing Series G cheques, the cap table is crowded, the dilution math is ugly, and the next stop is either an IPO or a down-round reset. Alan was founded in 2016, so the path here is roughly a decade of raises before landing at €5.5B.

What the filings confirm:

• Round: €480M Series G
• Post-money valuation: €5.5B
• Lead: Prosus
• Participating investor: Teachers' Venture Growth (the late-stage platform of Ontario Teachers' Pension Plan, Canada's largest single-profession pension plan)
• Counsel to TVG: Goodwin Procter, Paris PE team — Benjamin Garçon leading, with Louis Taslé d'Héliand and Grégoire Mongis on corporate
• Closing: subject to regulatory approvals

What they don't disclose, and what actually matters at this stage: primary versus secondary split, option pool refresh, and whether existing holders got any liquidity. At a G-round, somebody usually cashes out. If the round is mostly primary, the €5.5B is a real cost basis to defend; if it's mostly secondary, it's a partial exit dressed as a financing.

The LP Read

Ontario Teachers' writing into a French health insurer at €5.5B is a positioning signal — not about Alan specifically, but about where the big Canadian pools are parking late-stage euros. When TVG moves at this size, the smaller funds tend to follow six to twelve months later, usually through co-invest.

Three things to track:

• Regulatory clock. Solvency II, ACPR oversight, capital buffers. "Digital-first" is a marketing line; the regulator doesn't grade your app design. The approval timeline is the real milestone here.
• Liquidity path. A €5.5B G-round in EU health insurance usually points toward a Paris or Amsterdam listing. Watch for prospectus leaks and banking-mandate chatter.
• Prosus's posture. Prosus has been a serial writer into European tech. When they lead at the G, they're usually anchoring an exit narrative, not just underwriting the next bridge. If Prosus is rotating out at IPO, TVG just became the bag-holder with regulatory upside.

What this actually means for LPs: this is late-stage venture, not growth equity. The bet is the exit, and the exit now runs through a regulator who has no reason to be friendly.